In 2017, a guideline update stripped metronidazole of its first-line therapy designation and crowned oral vancomycin as initial therapy for all C difficile infection cases.
Rachel Britt, PharmD*
Advertisement
Articles by Rachel Britt, PharmD*
Advertisement
Latest Updated Articles
- Entering the Ring: Oral Vancomycin Versus Metronidazole for C difficile Infection and the Risk of Vancomycin-Resistant Enterococcus
Published: December 2nd 2019 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Phase 3 Trial Confirms Superior Efficacy of Oral Pritelivir for Refractory HSV in Immunocompromised Patients
2
Invivyd Announces FDA Clearance of IND Application for VYD2311 and Advancement of REVOLUTION Clinical Program
3
Top Infectious Disease News Stories Week of October 11-October 17
4
Developing the Next Generation of Rifamycins for Non-TB Mycobacteria in a Postantibiotic Era
5
